Valuation: Sanofi

Market Cap 87.68B 99.86B 80.7B 75.2B 142B 9,494B 145B 971B 376B 4,660B 375B 367B 16,218B P/E 2026 *
10.9x
P/E 2027 * 10.1x
Enterprise Value 98.14B 112B 90.34B 84.18B 159B 10,627B 162B 1,087B 421B 5,216B 420B 411B 18,155B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.88x
Free-Float
89%
Yield 2026 *
5.83%
Yield 2027 * 6.17%
1 day-2.88%
1 week-0.50%
Current month-2.88%
1 month-1.39%
3 months-11.78%
6 months-12.02%
Current year-12.02%
1 week 72.96
Extreme 72.96
78
1 month 71.27
Extreme 71.27
78.28
Current year 71.27
Extreme 71.27
84.9
1 year 71.27
Extreme 71.27
93
3 years 71.27
Extreme 71.27
111
5 years 71.27
Extreme 71.27
111
10 years 63.15
Extreme 63.15
111
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer 51 2023-09-10
Director TitleAgeSince
Director/Board Member 60 2019-04-29
Director/Board Member 57 2020-04-27
Director/Board Member 64 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-2.88%-0.50% - - 103B
-0.64%+6.67%+53.59%+154.11% 1,070B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 445B
-1.20%-0.96%+26.12%+20.22% 329B
-1.74%-0.40%+33.19%+22.86% 290B
-1.25%+0.53%+27.68%+38.89% 287B
+2.99%+4.00%-26.09%-41.06% 213B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 157B
Average -0.49%+1.69%+27.41%+51.22% 399.58B
Weighted average by Cap. -0.32%+2.73%+38.21%+76.14%

Financials

2026 *2027 *
Net sales 47.09B 53.64B 43.35B 40.39B 76.18B 5,100B 77.73B 521B 202B 2,503B 201B 197B 8,712B 50.03B 56.98B 46.05B 42.91B 80.93B 5,418B 82.58B 554B 215B 2,659B 214B 209B 9,255B
Net income 8.15B 9.28B 7.5B 6.99B 13.18B 882B 13.44B 90.17B 34.94B 433B 34.83B 34.08B 1,507B 8.95B 10.2B 8.24B 7.68B 14.49B 970B 14.78B 99.14B 38.41B 476B 38.29B 37.47B 1,656B
Net Debt 10.47B 11.92B 9.63B 8.98B 16.93B 1,133B 17.28B 116B 44.9B 556B 44.76B 43.79B 1,936B 6.3B 7.18B 5.8B 5.4B 10.19B 682B 10.4B 69.75B 27.03B 335B 26.94B 26.36B 1,165B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-07-01 €73.06 -2.88% 3,051
26-06-30 €75.23 -0.38% 1,885
26-06-29 €75.52 +0.75% 2,787
26-06-26 €74.96 +1.72% 5,592
26-06-25 €73.69 +0.35% 772
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
73.05EUR
Average target price
96.70EUR
Spread / Average Target
+32.38%

Quarterly revenue - Rate of surprise